Our results strongly suggest that absence of adipose ANGPTL4 reduces atherosclerosis progression by decreasing circulating proatherogenic lipoproteins, inflammatory cytokines, and vascular inflammation (Figure 9). This evidence concerns the gene ANGPTL4 and atherosclerosis.